美股
Matinas BioPharma Receives NYSE Notice
Matinas BioPharma Holdings has received a notice from the NYSE regarding a compliance issue, putting the company's listing status under review.
Yaya Financial NewsAsia's Fastest Financial NewsYaya Financial NewsAsia's Fastest Financial NewsMatinas BioPharma Holdings has received a notice from the NYSE regarding a compliance issue, putting the company's listing status under review.